Tonight the Technology Impact Awards (TIAs) marked their 30th Anniversary announcing 9 companies as award winners and inducting 8 leaders to the Innovators Hall of Fame at the annual awards show. “BC Tech is proud to have played a part in the journey of so many BC tech icons and success stories across our 30-year […]
AbCellera
BC Tech Unveils Finalists For 2023 Technology Impact Awards
The BC Tech Association has announced the finalists for the 2023 Technology Impact Awards, the 30th anniversary of the TIAs. The announcement was hosted in downtown Vancouver at The Den at Bentall Centre with a live online audience. “This year marks a big milestone for BC Tech, as we celebrate our 30th Anniversary alongside the companies […]
Connecting The Dots: May 2023
Each month, the team at Switchboard (an Earnscliffe Strategies company) connects the dots between the trends, headlines and narratives informing the B.C. tech sector. For May’s Connecting The Dots, the Switchboard team discusses recent announcement from Minister François-Philippe Champagne’s visit to B.C., breaks down the recent Conversations Live with Stuart McNish panel on the topic […]
Innovation District Arises in Vancouver as City Endures State of Flux
Last year, Keltic Canada Development broke ground on a new health-innovation project. The Vancouver-based Keltic teamed up with global medical technology company Masimo to develop a multi-level facility. “We’re proud to see that our reputation as a leader in the life sciences sector has helped lead Masimo to expand their operations in B.C.,” stated Ravi […]
Province and Federal Government Fuel AbCellera’s Vancouver Expansion for Medical Breakthroughs
A new commitment from the Province and the Government of Canada to AbCellera will support the made-in-B.C. anchor company to expand in Vancouver. Building on B.C.’s new Life Sciences and Biomanufacturing Strategy, the Province of B.C. is contributing $75 million toward AbCellera’s expansion in Vancouver. The Government of Canada is contributing $225 million toward the […]
Why Local BC Tech Companies Are Sweatin’ For Science
This year, the several BC-based tech companies have rallied together to ‘Sweat for Science’ as a part of the Science Fair Foundation BC’s annual fundraiser, put together in partnership with AbCellera. Among the other key participating teams are Genome BC and Aspect Biosystems. Participating in this event helps raise funds and awareness for science fairs […]
Science Fair Foundation BC Challenges STEM Community to Sweat For Science
The Science Fair Foundation BC has opened registration for 2023 Sweatin’ For Science, presented by AbCellera. This fitness fundraiser, the Foundation’s largest annual science, technology, engineering and mathematics (STEM) fundraising and awareness campaign, is returning for the third straight year this May. This year’s theme is “Sci-Fi to Reality” and will explore advancements in technology […]
The Top 25 Healthcare Technology Leaders of Vancouver for 2022
Moove It’s Health Index uses data to reveal the cities with the most developed healthtech ecosystems in the world and the software consulting firm recently ranked Vancouver third among Canadian cities for advancement of their healthtech sectors. Supporting Vancouver’s ranking as a global city leading the technological advancement of healthcare, the Healthcare Technology Report has announced […]
AbCellera Breaks Ground On Phase 2 Of Global HQ In Vancouver
Vancouver biotech anchor AbCellera has broken ground at the Mount Pleasant address that will soon be home to Phase 2 of the Vancouver-grown company’s 380,000-square-foot global headquarters. AbCellera’s leadership team were joined by members of the local biotech ecosystem to celebrate the future, world-class biotech campus that will employ hundreds of highly skilled technical personnel. […]
AbCellera-Discovered Antibody Receives FDA Emergency Use Authorization
AbCellera‘s second antibody developed through AbCellera’s collaboration with Eli Lilly, bebtelovimab (LY-CoV1404), has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). Bebtelovimab is authorized for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for […]